HOUSE-BILL 9102: H.R.9102 - BINSA Act
AI-Powered Summary
HOUSE-BILL 9102 aims to regulate biotechnology investments and cross-border transactions, particularly with Chinese firms, to enhance national security. The bill addresses major themes of commerce regulation, national security, and the protection of intellectual property rights. Key provisions include the establishment of definitions for 'prohibited technology' and 'notifiable technology,' which may impose restrictions on individuals and companies in the biotechnology sector. Implementation will require individuals to comply with new regulations and navigate potential scrutiny of their international collaborations. The bill raises constitutional concerns regarding commerce rights and free association, while also highlighting the balance between national security interests and individual freedoms. Potential impacts include increased regulatory burdens on biotechnology entrepreneurs, limitations on international innovation, and a need for compliance with evolving rules.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
HOUSE-BILL 9102 presents substantial constitutional implications for individuals, particularly in the biotechnology sector. The bill's focus on national security may lead to restrictions that infringe upon individual rights, particularly economic rights and equal protection under the law.
Key Individual Rights Affected
- Economic rights to engage in commerce
- Equal protection under the Fourteenth Amendment
- Freedom of speech and expression
Constitutional Provisions Most Relevant
- Fourteenth Amendment (Equal Protection Clause)
- First Amendment (Freedom of Speech)
- Fifth Amendment (Due Process)
Potential Constitutional Challenges Or Support
Challenges
- Discrimination against specific demographic groups could lead to equal protection claims.
- Broad definitions of prohibited technologies may lead to excessive government control, raising due process concerns.
Support
- The government may argue the necessity of the bill for national security, which is a recognized justification for certain restrictions.
Summary Of Individual Impact
The bill could lead to job losses and reduced economic opportunities for individuals in the biotechnology sector, particularly affecting marginalized communities. Additionally, restrictions on technology transfer may limit access to innovative healthcare solutions, disproportionately impacting vulnerable populations such as seniors and those with chronic health conditions. The potential for unequal treatment based on demographic characteristics raises significant constitutional concerns under the Equal Protection Clause.
Constitutional Analysis
This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 9102 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreeTimeline
June 2, 2026
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat